The PILLAR Study is only for people who, experienced at least one exacerbation at least in the last 12 months, who has been prescribed COPD maintenance triple therapy (a combination of an anti-inflammatory inhaled medication and two inhaled bronchodilators).
STUDY SUMMARY
ELIGIBILITY CRITERIA
- Be at least 40 years of age
- Have COPD and chronic bronchitis with current symptoms
- Be a current or former smoker who quit 6 or more months before entering the study
- Have had at least one documented COPD exacerbation in the past 12 months

GET STARTED